{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T15:38:59Z","timestamp":1771515539078,"version":"3.50.1"},"reference-count":19,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.3892\/etm.2016.3301","type":"journal-article","created":{"date-parts":[[2016,4,27]],"date-time":"2016-04-27T08:47:54Z","timestamp":1461746874000},"page":"445-450","source":"Crossref","is-referenced-by-count":16,"title":["Treatment effect of cyclosporine A in patients with painful bladder syndrome\/interstitial cystitis: A systematic review"],"prefix":"10.3892","volume":"12","author":[{"given":"ZHIKUI","family":"WANG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LEI","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2016,4,27]]},"reference":[{"key":"key20180108133448_b1-etm-0-0-3301","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.juro.2006.11.084","article-title":"BACH Survey Investigators: Prevalence of painful bladder symptoms and effect on quality of life in black, Hispanic and white men and women","volume":"177","author":"Clemens","year":"2007","journal-title":"J Urol"},{"key":"key20180108133448_b2-etm-0-0-3301","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-1-4471-3293-6_4","article-title":"Epidemiology of interstitial cystitis","author":"Held","year":"1990","journal-title":"Interstitial Cystitis"},{"key":"key20180108133448_b3-etm-0-0-3301","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0022-5347(17)41529-1","article-title":"Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases workshop on interstitial cystitis, National Institutes of Health, Bethesda, Maryland, August 28\u201329, 1987","volume":"140","author":"Gillenwater","year":"1988","journal-title":"J Urol"},{"key":"key20180108133448_b4-etm-0-0-3301","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/0961203309350320","article-title":"Efficacy and safety of cyclosporine A in patients with refractory systemic lupus erythematosus in a daily clinical practice","volume":"19","author":"Ogawa","year":"2010","journal-title":"Lupus"},{"key":"key20180108133448_b5-etm-0-0-3301","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1111\/j.1600-6143.2011.03511.x","article-title":"Cyclosporine A or tacrolimus for hepatitis C recurrence? An old debate","volume":"11","author":"Forns","year":"2011","journal-title":"Am J Transplant"},{"issue":"Suppl 2","key":"key20180108133448_b6-etm-0-0-3301","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1111\/j.1468-3083.2011.03992.x","article-title":"Oral cyclosporin in psoriasis: A systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis","volume":"25","author":"Maza","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key20180108133448_b7-etm-0-0-3301","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1572-0241.2007.01718.x","article-title":"Adverse events associated with the use of cyclosporine in patients with inflammatory bowel disease","volume":"103","author":"Sternthal","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"key20180108133448_b8-etm-0-0-3301","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2165\/00063030-199810060-00002","article-title":"Cyclosporin in rheumatoid arthritis: Monitoring for adverse effects and clinically significant drug interactions","volume":"10","author":"Dijkmans","year":"1998","journal-title":"BioDrugs"},{"key":"key20180108133448_b9-etm-0-0-3301","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysis","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"key20180108133448_b10-etm-0-0-3301","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: Is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"key20180108133448_b11-etm-0-0-3301","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3109\/21681805.2013.788552","article-title":"Nitric oxide as a marker for evaluation of treatment effect of cyclosporine A in patients with bladder pain syndrome\/interstitial cystitis type 3C","volume":"47","author":"Ehr\u00e9n","year":"2013","journal-title":"Scand J Urol"},{"issue":"Supp 13","key":"key20180108133448_b12-etm-0-0-3301","doi-asserted-by":"crossref","first-page":"e462","DOI":"10.1016\/S1569-9056(14)60456-5","article-title":"462 5-year follow-up of patients with refractory interstitial cystitis treated with cyclosporine A: A prospective single-institution study","author":"Chade","year":"2014","journal-title":"Eur Urol"},{"key":"key20180108133448_b13-etm-0-0-3301","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.juro.2012.06.023","article-title":"Cyclosporine A for refractory interstitial cystitis\/bladder pain syndrome: Experience of 3 tertiary centers","volume":"188","author":"Forrest","year":"2012","journal-title":"J Urol"},{"key":"key20180108133448_b14-etm-0-0-3301","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1097\/01.ju.0000125139.91203.7a","article-title":"Long-term outcome of patients with interstitial cystitis treated with low dose cyclosporine A","volume":"171","author":"Sairanen","year":"2004","journal-title":"J Urol"},{"key":"key20180108133448_b15-etm-0-0-3301","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/S0022-5347(01)66137-8","article-title":"Cyclosporine in severe interstitial cystitis","volume":"155","author":"Forsell","year":"1996","journal-title":"J Urol"},{"key":"key20180108133448_b16-etm-0-0-3301","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1097\/01.ju.0000181808.45786.84","article-title":"Cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis: A randomized comparative study","volume":"174","author":"Sairanen","year":"2005","journal-title":"J Urol"},{"key":"key20180108133448_b17-etm-0-0-3301","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.urology.2007.11.055","article-title":"Urinary epidermal growth factor and interleukin-6 levels in patients with painful bladder syndrome\/interstitial cystitis treated with cyclosporine or pentosan polysulfate sodium","volume":"71","author":"Sairanen","year":"2008","journal-title":"Urology"},{"key":"key20180108133448_b18-etm-0-0-3301","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/nau.20350","article-title":"Potassium sensitivity test (PST) as a measurement of treatment efficacy of painful bladder syndrome\/interstitial cystitis: A prospective study with cyclosporine A and pentosan polysulfate sodium","volume":"26","author":"Sairanen","year":"2007","journal-title":"Neurourol Urodyn"},{"key":"key20180108133448_b19-etm-0-0-3301","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3892\/etm.2013.1446","article-title":"Cyclosporine A for the treatment of refractory nephritic syndrome with renal dysfunction","volume":"7","author":"Gao","year":"2014","journal-title":"Exp Ther Med"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/etm.2016.3301\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T23:39:07Z","timestamp":1515454747000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/etm.2016.3301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,27]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,4,27]]},"published-print":{"date-parts":[[2016,7]]}},"alternative-id":["10.3892\/etm.2016.3301"],"URL":"https:\/\/doi.org\/10.3892\/etm.2016.3301","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,27]]}}}